Ultima Genomics Funding: $700M Raised, Series C (2022)
Ultima Genomics is based in Palo Alto. It has raised $700M in total funding. Latest round: Series C.
Ultima Genomics funding overview
Ultima Genomics is based in Palo Alto. Ultima Genomics has raised $700M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in May 2022. The round record for Ultima Genomics runs through 2022; nothing later has been disclosed. Investors on record include General Atlantic, Andreessen Horowitz, Khosla Ventures, Lightspeed, Playground Global, D1 Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Ultima Genomics at a glance
Total raised
$700M
Latest round
Series C
Latest round date
May 2022
Headquarters
Palo Alto
Notable investors
General Atlantic, Andreessen Horowitz, Khosla Ventures, Lightspeed, Playground Global, D1 Capital, Founders Fund, Marius Nacht
Frequently asked about Ultima Genomics funding
How much has Ultima Genomics raised?
Ultima Genomics has raised $700M in total disclosed funding across the rounds on record.
Who has invested in Ultima Genomics?
General Atlantic, Andreessen Horowitz, Khosla Ventures, Lightspeed, Playground Global, D1 Capital are named among the investors backing Ultima Genomics.
What was the latest Ultima Genomics funding round?
The most recent disclosed round is a Series C, announced in May 2022.
Where is Ultima Genomics based?
Ultima Genomics is based in Palo Alto.
When did Ultima Genomics last raise?
The last disclosed Ultima Genomics round closed in May 2022 at Series C.
Ultima Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Palo Alto below to benchmark round size and investor mix.
